Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2969240 | 0.83 | CYP3A4 (0.50) | CYP3A4TRPM8LPAR3LPAR1LPAR2 | |
| SCHEMBL13618652 | 0.82 | CYP3A4 (0.58) | CYP3A4TRPM8LPAR3LPAR1LPAR2 | |
| SCHEMBL7804495 | 0.82 | CYP3A4 (0.48) | CYP3A4TRPM8LPAR3LPAR1LPAR2 | |
| SCHEMBL11345366 | 0.80 | CYP3A4 (0.47) | CYP3A4LPAR3LPAR1LPAR2TSHR | |
| SCHEMBL19595699 | 0.80 | CYP3A4 (0.56) | CYP3A4LPAR3LPAR1LPAR2TSHR | |
| SCHEMBL21812127 | 0.79 | CYP3A4 (0.50) | CYP3A4TRPM8LPAR3LPAR1LPAR2 | |
| SCHEMBL7804490 | 0.79 | CYP3A4 (0.50) | CYP3A4TRPM8LPAR3LPAR1LPAR2 | |
| SCHEMBL3291222 | 0.78 | CYP3A4 (0.54) | CYP3A4LPAR3LPAR1LPAR2TSHR | |
| SCHEMBL11687397 | 0.77 | CYP3A4 (0.52) | CYP3A4LPAR3LPAR1LPAR2TSHR | |
| SCHEMBL14495223 | 0.77 | TSHR (0.46) | CYP3A4TRPM8TSHRGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010025116-A1 | Aluminum salts of phosphinic acids | TICONA GMBH | 2001-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010025116-A1 | Aluminum salts of phosphinic acids | PPA1, PHOSPHO1, AGPS | CYP3A4 4686/4885TRPM8 2749/4885LPAR3 1176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.